Study With Healthy Japanese and Non-Asian Participants With BMS-986231

Summary

The purpose of this Phase 1 study is to evaluate the safety, tolerability, PK, and pharmacodynamics (PD) of BMS-986231 in healthy Japanese and Non-Asian participants. There is no formal hypothesis to be statistically tested.

Timeline

Start

2016-10-04

Primary completion

2017-05-26

Completion

2017-05-26

Drugs

Indications